Roche flu drug to carry new caution in U.S.
14th Nov 2006, 00:27 GMT
WASHINGTON (Reuters) - Roche AG's influenza drug Tamiflu will come with a new caution urging close monitoring of patients for abnormal behavior such as delirium and self-injury, U.S. regulators said on Monday.
Roche flu drug to carry new caution in U.S. related news:
- FDA staff urges new caution on Roche flu drug — Reuters: Health
- FDA staff urges new caution on Roche flu drug (Reuters) — Yahoo! News: Top Stories
- FDA Urges Caution on Flu Drug — WSJ.com: What's News US
- Bizarre behavior linked to Tamiflu — Daily Herald - Top Stories
- FDA Orders Caution Over the use of Tamiflu — NPR Topics: Nation
- Psychiatric warning put on flu drug — SacBee -- News
- Flu Drug Label Will Warn of Risks, FDA Says — washingtonpost.com - A Section
- Feds: Flu drug may causeodd behavior — New York Daily News Online -- Health
- Regulator queries safety of anti-flu drug — Guardian Unlimited World Latest
- Concerns raised about flu treatment — HeraldNet.com All News
Latest news from Reuters: Health:
- Gene chip test identifies bird flu strains
- Bristol arthritis drug effective in children: study
- World's poor still deprived of drugs: activists
- Study questions radiation after prostate removal
- Chocolate addiction leads to sweet discovery
- Researchers spur growth of adult brain stem cells
- Angioplasty no help for heart attack victims who wait
- Diabetics fare better with drug-eluting stents
- Very obese fare worse after colon cancer diagnosis
- Companies vow to rein in kid junk food ads